BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29290282)

  • 1. RACK1 is an organ-specific prognostic predictor in OSCC.
    Liu S; Liu J; Wang J; Cheng J; Zeng X; Ji N; Li J; Chen Q
    Oral Oncol; 2018 Jan; 76():22-26. PubMed ID: 29290282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
    Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
    Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the correlation between combined detection of RACK1 and M2/M1 in oral squamous cell carcinoma and prognosis of the patients].
    Zhu J; Xu T; Song DH; Wu SB
    Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):517-522. PubMed ID: 36758601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
    Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
    Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
    Li J; Feng X; Sun C; Zeng X; Xie L; Xu H; Li T; Wang R; Xu X; Zhou X; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Jiang L; Wang Z; Chen Q
    EBioMedicine; 2015 Aug; 2(8):851-8. PubMed ID: 26425691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.
    Wang Z; Jiang L; Huang C; Li Z; Chen L; Gou L; Chen P; Tong A; Tang M; Gao F; Shen J; Zhang Y; Bai J; Zhou M; Miao D; Chen Q
    Mol Cell Proteomics; 2008 Sep; 7(9):1639-50. PubMed ID: 18458027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
    Bu J; Bu X; Liu B; Chen F; Chen P
    Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of RACK1 and peripheral blood M2/M1 monocyte ratio on the prognosis of patients with oral squamous cell carcinoma.
    Liu H; Wu R; Bi L; Xu X; Chen H
    Pak J Pharm Sci; 2023 Mar; 36(2(Special)):631-638. PubMed ID: 37548201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
    Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
    BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
    Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67.
    Wang Z; Zhang B; Jiang L; Zeng X; Chen Y; Feng X; Guo Y; Chen Q
    Eur J Cancer; 2009 Feb; 45(3):490-6. PubMed ID: 19087901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
    Li Y; Li R; Qin H; He H; Li S
    Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
    Zhao C; Zou H; Wang J; Shen J; Liu H
    DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
    Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.
    Cai M; Tan R; Huang Y; Chen X; Kong Q; Guo K; Xu M
    Pathol Oncol Res; 2021; 27():641042. PubMed ID: 34257607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.